Could an MS pill slow Alzheimer's brain shrinkage?
NCT ID NCT06639282
Summary
This study is testing whether a drug called siponimod, already approved for multiple sclerosis, can slow the progression of mild Alzheimer's disease. About 105 participants will take either the drug or a placebo for one year, followed by a six-month observation period. The main goals are to see if the drug is safe for people with Alzheimer's and if it can slow the rate of brain shrinkage, which is a key sign of the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St. Joseph's Hospital and Medical Center
RECRUITINGPhoenix, Arizona, 85013, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.